These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Witteman BP; Conchillo JM; Rinsma NF; Betzel B; Peeters A; Koek GH; Stassen LP; Bouvy ND Am J Gastroenterol; 2015 Apr; 110(4):531-42. PubMed ID: 25823768 [TBL] [Abstract][Full Text] [Related]
44. A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD). Savarino E; Zentilin P; Marabotto E; Bodini G; Della Coletta M; Frazzoni M; de Bortoli N; Martinucci I; Tolone S; Pellegatta G; Savarino V Expert Opin Pharmacother; 2017 Sep; 18(13):1333-1343. PubMed ID: 28754071 [TBL] [Abstract][Full Text] [Related]
45. The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors. Yamashita H; Kanamori A; Kano C; Hashimura H; Matsumoto K; Tsujimae M; Yoshizaki T; Momose K; Obata D; Eguchi T; Fujita M; Okada A Digestion; 2017; 96(1):52-59. PubMed ID: 28662503 [TBL] [Abstract][Full Text] [Related]
46. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life. Takeshima F; Hashiguchi K; Onitsuka Y; Tanigawa K; Minami H; Matsushima K; Akazawa Y; Shiozawa K; Yamaguchi N; Taura N; Ohnita K; Ichikawa T; Isomoto H; Nakao K Med Sci Monit; 2015 Dec; 21():4111-21. PubMed ID: 26719012 [TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of once-daily esomeprazole for the treatment of gastroesophageal reflux disease in neonatal patients. Davidson G; Wenzl TG; Thomson M; Omari T; Barker P; Lundborg P; Illueca M J Pediatr; 2013 Sep; 163(3):692-8.e1-2. PubMed ID: 23800403 [TBL] [Abstract][Full Text] [Related]
48. Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease. Yadlapati R; DeLay K Med Clin North Am; 2019 Jan; 103(1):15-27. PubMed ID: 30466671 [TBL] [Abstract][Full Text] [Related]
49. Effect of Acid Suppression on Peripheral T-Lymphocyte Subsets and Immunohistochemical Esophageal Mucosal Changes in Patients With Gastroesophageal Reflux Disease. Ahmed Osman H; Aly SS; Mahmoud HS; Ahmed EH; Salah Eldin EM; Abdelrahim EA; El Masry MA; Herdan RA; Hassan MH J Clin Gastroenterol; 2019 Oct; 53(9):e362-e370. PubMed ID: 30119091 [TBL] [Abstract][Full Text] [Related]
50. Proton pump inhibitors in the management of gastroesophageal reflux disease. Hrelja N; Zerem E Med Arh; 2011; 65(1):52-5. PubMed ID: 21534455 [TBL] [Abstract][Full Text] [Related]
51. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Caro JJ; Salas M; Ward A Clin Ther; 2001 Jul; 23(7):998-1017. PubMed ID: 11519776 [TBL] [Abstract][Full Text] [Related]
52. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Poe RH; Kallay MC Chest; 2003 Mar; 123(3):679-84. PubMed ID: 12628862 [TBL] [Abstract][Full Text] [Related]
53. Limited ability of the proton-pump inhibitor test to identify patients with gastroesophageal reflux disease. Bytzer P; Jones R; Vakil N; Junghard O; Lind T; Wernersson B; Dent J Clin Gastroenterol Hepatol; 2012 Dec; 10(12):1360-6. PubMed ID: 22813439 [TBL] [Abstract][Full Text] [Related]
55. Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study. Foocharoen C; Chunlertrith K; Mairiang P; Mahakkanukrauh A; Suwannaroj S; Namvijit S; Wantha O; Nanagara R Sci Rep; 2020 Jan; 10(1):769. PubMed ID: 31964957 [TBL] [Abstract][Full Text] [Related]
56. Comparative effectiveness and tolerability of esomeprazole and omeprazole in gastro-esophageal reflux disease: A systematic review and meta-analysis. Qi Q; Wang R; Liu L; Zhao F; Wang S Int J Clin Pharmacol Ther; 2015 Oct; 53(10):803-10. PubMed ID: 26329348 [TBL] [Abstract][Full Text] [Related]